GlassScriptPhysician profile
Simon Daniel Xavier Thebault
NPI 1174258305
$19,993.35
in general payments reported to CMS, 2019-2025
5 companies · $7,151 in 2025
The $7,151 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12K · 2024: $999 · 2025: $7,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $3,040 · Travel and Lodging: $1,208 · Education: $12.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,732.50 |
| Food and Beverage | $3,039.88 |
| Travel and Lodging | $1,208.41 |
| Education | $12.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $10,894.82 | 2023-2024 | |
| Hoffmann-La Roche Limited | $7,151.23 | 2025 | Ocrevus |
| Emd Serono, INC. | $1,569.42 | 2023-2024 | |
| Celgene Corporation | $328.38 | 2023-2024 | Zeposia |
| Novartis Pharmaceuticals Corporation | $49.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Thebault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.